Back
ACADIA Pharmaceuticals 10K Form
Sell
39
ACAD
ACADIA Pharmaceuticals
Last Price:
16.20
Seasonality Move:
23.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
| 2024-02-28 | 10K | ACAD/ACADIA Pharmaceuticals Annual |
| 2023-11-03 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
| 2023-08-03 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
| 2023-05-08 | 10Q | ACAD/ACADIA Pharmaceuticals Quarterly |
| 2023-02-28 | 10K | ACAD/ACADIA Pharmaceuticals Annual |
Receive ACAD News And Ratings
See the #1 stock for the next 7 days that we like better than ACAD
ACAD Financial Statistics
Sales & Book Value
| Annual Sales: | $726.44M |
|---|---|
| Cash Flow: | $63.18M |
| Price / Cash Flow: | 13.32 |
| Annual Sales: | $3.47 |
| Price / Book: | 4.69 |
Profitability
| EPS (TTM): | 0.78000 |
|---|---|
| Net Income (TTM): | $128.51M |
| Gross Margin: | $684.8M |
| Return on Equity: | 27.32% |
| Return on Assets: | 15.57% |
ACADIA Pharmaceuticals Earnings Forecast
Key ACADIA Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 19 years for ACAD is 94.27%.
- The Selling, General & Administrative Expenses for ACAD have been equal to 55.97% of Gross Profit Margin.
- The Research & Development expenses have been 48.40% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of ACAD is -8.44% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 11 years.
ACADIA Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ACAD |
| CUSIP: | 004225 |
| Website: | acadia.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.29 |
| Quick Ratio: | 1.96 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 20.64 |
ACAD Technical Analysis vs Fundamental Analysis
Sell
39
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy or a Sell?
-
ACADIA Pharmaceuticals stock is rated a Sell
The current ACADIA Pharmaceuticals [ACAD] share price is $16.27. The Score for ACAD is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.